|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stein U and Schlag PM: Clinical,
biological, and molecular aspects of metastasis in colorectal
cancer. Recent Results Cancer Res. 176:61–80. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Deliu IC, Georgescu EF and Bezna MC:
Analysis of prognostic factors in colorectal carcinoma. Rev Med
Chir Soc Med Nat Iasi. 118:808–816. 2014.PubMed/NCBI
|
|
4
|
Sethi N and Kang Y: Unravelling the
complexity of metastasis-molecular understanding and targeted
therapies. Nat Rev Cancer. 11:735–748. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wanebo HJ, LeGolvan M, Paty PB, Saha S,
Zuber M, D'Angelica MI and Kemeny NE: Meeting the biologic
challenge of colorectal metastases. Clin Exp Metastasis.
29:821–839. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stein U, Walther W, Arlt F, Schwabe H,
Smith J, Fichtner I, Birchmeier W and Schlag PM: MACC1, a newly
identified key regulator of HGF-MET signaling, predicts colon
cancer metastasis. Nat Med. 15:59–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stein U, Dahlmann M and Walther W:
MACC1-more than metastasis? Facts and predictions about a novel
gene. J Mol Med (Berl). 88:11–18. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kokoszyńska K, Kryński J, Rychlewski L and
Wyrwicz LS: Unexpected domain composition of MACC1 links MET
signaling and apoptosis. Acta Biochim Pol. 56:317–323.
2009.PubMed/NCBI
|
|
9
|
Wang R, Wei Z, Jin H, Wu H, Yu C, Wen W,
Chan LN, Wen Z and Zhang M: Autoinhibition of UNC5b revealed by the
cytoplasmic domain structure of the receptor. Mol Cell. 33:692–703.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ipsaro JJ, Huang L and Mondragon A:
Structures of the spectrin-ankyrin interaction binding domains.
Blood. 113:5385–5393. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Reed JC, Doctor KS and Godzik A: The
domains of apoptosis: A genomics perspective. Sci STKE.
2004:re92004.PubMed/NCBI
|
|
12
|
Shirahata A, Sakata M, Kitamura Y,
Sakuraba K, Yokomizo K, Goto T, Mizukami H, Saito M, Ishibashi K,
Kigawa G, et al: MACC 1 as a marker for peritoneal-disseminated
gastric carcinoma. Anticancer Res. 30:3441–3444. 2010.PubMed/NCBI
|
|
13
|
Ge SH, Wu XJ, Wang XH, Xing XF, Zhang LH,
Zhu YB, Du H, Dong B, Hu Y and Ji JF: Over-expression of
metastasis-associated in colon cancer-1 (MACC1) associates with
better prognosis of gastric cancer patients. Chin J Cancer Res.
23:153–159. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang L, Wu Y, Lin L, Liu P, Huang H, Liao
W, Zheng D, Zuo Q, Sun L, Huang N, et al: Metastasis-associated in
colon cancer-1 upregulation predicts a poor prognosis of gastric
cancer, and promotes tumor cell proliferation and invasion. Int J
Cancer. 133:1419–1430. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma J, Ma J, Meng Q, Zhao ZS and Xu WJ:
Prognostic value and clinical pathology of MACC-1 and c-MET
expression in gastric carcinoma. Pathol Oncol Res. 19:821–832.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo T, Yang J, Yao J, Zhang Y, Da M and
Duan Y: Expression of MACC1 and c-Met in human gastric cancer and
its clinical significance. Cancer Cell Int. 13:1212013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun L, Duan J, Jiang Y, Wang L, Huang N,
Lin L, Liao Y and Liao W: Metastasis-associated in colon cancer-1
upregulates vascular endothelial growth factor-C/D to promote
lymphangiogenesis in human gastric cancer. Cancer Lett.
357:242–253. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Burock S, Herrmann P, Wendler I,
Niederstrasser M, Wernecke KD and Stein U: Circulating metastasis
associated in colon cancer 1 transcripts in gastric cancer patient
plasma as diagnostic and prognostic biomarker. World J
Gastroenterol. 21:333–341. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shimokawa H, Uramoto H, Onitsuka T, et al:
Macc1 amplification predicts postoperative recurrence in lung
adenocarcinoma. Ann Oncol. 21:24–25. 2010.
|
|
20
|
Shimokawa H, Uramoto H, Onitsuka T,
Chundong G, Hanagiri T, Oyama T and Yasumoto K: Overexpression of
MACC1 mRNA in lung adenocarcinoma is associated with postoperative
recurrence. J Thorac Cardiovasc Surg. 141:895–898. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gu CD, Uramoto H, Onitsuka T, Shimokawa H,
Iwanami T, Nakagawa M, Oyama T and Tanaka F: Molecular Diagnosis of
MACC1 status in lung adenocarcinoma by immunohistochemical
analysis. Anticancer Res. 31:1141–1145. 2011.PubMed/NCBI
|
|
22
|
Hu X, Fu X, Wen S, Zou X and Liu Y:
Prognostic value of MACC1 and c-met expressions in non-small cell
lung cancer. Zhongguo Fei Ai Za Zhi. 15:399–403. 2012.(In Chinese).
PubMed/NCBI
|
|
23
|
Wang Z, Li Z, Wu C, Wang Y, Xia Y, Chen L,
Zhu Q and Chen Y: MACC1 overexpression predicts a poor prognosis
for non-small cell lung cancer. Med Oncol. 31:7902014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Z, Cai M, Weng Y, Zhang F, Meng D,
Song J, Zhou H and Xie Z: Circulating MACC1 as a novel diagnostic
and prognostic biomarker for nonsmall cell lung cancer. J Cancer
Res Clin Oncol. 141:1353–1361. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang Y, Zhang H, Cai J, Fang L, Wu J, Ye
C, Zhu X and Li M: Overexpression of MACC1 and its significance in
human breast cancer progression. Cell Biosci. 3:162013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Muendlein A, Hubalek M, Geller-Rhomberg S,
Gasser K, Winder T, Drexel H, Decker T, Mueller-Holzner E, Chamson
M, Marth C and Lang AH: Significant survival impact of MACC1
polymorphisms in HER2 positive breast cancer patients. Eur J
Cancer. 50:2134–2141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim GE, Lee JS, Park MH and Yoon JH:
Metastasis associated in colon cancer 1 predicts poor outcomes in
patients with breast cancer. Anal Quant Cytopathol Histpathol.
37:96–104. 2015.PubMed/NCBI
|
|
28
|
Qiu J, Huang P, Liu Q, Hong J, Li B, Lu C,
Wang L, Wang J and Yuan Y: Identification of MACC1 as a novel
prognostic marker in hepatocellular carcinoma. J Transl Med.
9:1662011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qu JH, Chang XJ, Lu YY, Bai WL, Chen Y,
Zhou L, Zeng Z, Wang CP, An LJ, Hao LY, et al: Overexpression of
metastasis-associated in colon cancer 1 predicts a poor outcome of
hepatitis B virus-related hepatocellular carcinoma. World J
Gastroenterol. 18:2995–3003. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chang XJ, Wang CP, Qu JH, Lu YY, Chen Y,
Bai WL, Gao XD, Hao LY, Xu GL, Wang H and Yang YP: Expression and
clinical significance of metastasis-associated in colon cancer 1
(MACC1) in HBV-related hepatocellular carcinoma. Zhonghua Zhong Liu
Za Zhi. 34:748–752. 2012.PubMed/NCBI
|
|
31
|
Yang YP, Qu JH, Chang XJ, Lu YY, Bai WL,
Dong Z, Wang H, An LJ, Xu ZX, Wang CP, et al: High intratumoral
metastasis-associated in colon cancer-1 expression predicts poor
outcomes of cryoablation therapy for advanced hepatocellular
carcinoma. J Transl Med. 11:412013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xie C, Wu J, Yun J, Lai J, Yuan Y, Gao Z,
Li M, Li J and Song L: MACC1 as a prognostic biomarker for
early-stage and AFP-normal hepatocellular carcinoma. PLoS One.
8:e642352013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie C, Li J, Xie DY, Wu JH, Li MF and Gao
ZL: 761 Macc1 protein: A promising immunomarker for the detection
of early stage and afp normal hepatocellular carcinomas. J Hepatol.
56:S2992012. View Article : Google Scholar
|
|
34
|
Gao S, Lin BY, Yang Z, Zheng ZY, Liu ZK,
Wu LM, Xie HY, Zhou L and Zheng SS: Role of overexpression of MACC1
and/or FAK in predicting prognosis of hepatocellular carcinoma
after liver transplantation. Int J Med Sci. 11:268–275. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ji D, Lu ZT, Li YQ, Liang ZY, Zhang PF, Li
C, Zhang JL, Zheng X and Yao YM: MACC1 Expression correlates with
PFKFB2 and survival in hepatocellular carcinoma. Asian Pac J Cancer
P. 15:999–1003. 2014. View Article : Google Scholar
|
|
36
|
Li Y, Lu Z, Liang Z, Ji D, Zhang P, Liu Q,
Zheng X and Yao Y: Metastasis-associated in colon cancer-1 is
associated with poor prognosis in hepatocellular carcinoma, partly
by promoting proliferation through enhanced glucose metabolism. Mol
Med Rep. 12:426–434. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun DW, Zhang YY, Qi Y, Liu GQ, Chen YG,
Ma J and Lv GY: Prognostic and clinicopathological significance of
MACC1 expression in hepatocellular carcinoma patients: A
meta-analysis. Int J Clin Exp Med. 8:4769–4777. 2015.PubMed/NCBI
|
|
38
|
Yao Y, Dou C, Lu Z, Zheng X and Liu Q:
MACC1 suppresses cell apoptosis in hepatocellular carcinoma by
targeting the HGF/c-MET/AKT pathway. Cell Physiol Biochem.
35:983–996. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang RT, Shi HR, Huang HL, Chen ZM, Liu
HN and Yuan ZF: Expressions of MACC1, HGF and C-met protein in
epithelial ovarian cancer and their significance. Nan Fang Yi Ke Da
Xue Xue Bao. 31:1551–1555. 2011.(In Chinese). PubMed/NCBI
|
|
40
|
Zhang RT, Ren F and Shi HR: Expression of
metastasis-associated in colon cancer-1 in different stages of
epithelial ovarian cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao.
36:47–51. 2014.(In Chinese). PubMed/NCBI
|
|
41
|
Li H, Zhang H, Zhao S, Shi Y, Yao J, Zhang
Y, Guo H and Liu X: Overexpression of MACC1 and the association
with hepatocyte growth factor/c-Met in epithelial ovarian cancer.
Oncol Lett. 9:1989–1996. 2015.PubMed/NCBI
|
|
42
|
Hu H, Tian D, Chen T, Han R, Sun Y and Wu
C: Metastasis-associated in colon cancer 1 is a novel
survival-related biomarker for human patients with renal pelvis
carcinoma. PLoS One. 9:e1001612014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jin Z, Xu N, Guo K, Xu P, Li P, Zhang Y,
Li X, Zheng S, Liu C, Xu A and Huang P: Increased expression of
metastasis-associated in colon cancer-1 in renal cell carcinoma is
associated with poor prognosis. Int J Clin Exp Pathol. 8:3857–3863.
2015.PubMed/NCBI
|
|
44
|
Yang T, Kong B, Kuang YQ, Cheng L, Gu JW,
Zhang JH, Shu HF, Yu SX, He WQ, Xing XM and Huang HD:
Overexpression of MACC1 protein and its clinical implications in
patients with glioma. Tumor Biol. 35:815–819. 2014. View Article : Google Scholar
|
|
45
|
Hagemann C, Fuchs S, Monoranu CM, Herrmann
P, Smith J, Hohmann T, Grabiec U, Kessler AF, Dehghani F, Löhr M,
et al: Impact of MACC1 on human malignant glioma progression and
patients unfavorable prognosis. Neuro Oncol. 15:1696–1709. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang Y, Hong Q, Wang J, Fang Y and Hu C:
Downregulated expression of metastasis associated in colon cancer 1
(MACC1) reduces gallbladder cancer cell proliferation and invasion.
Tumor Biol. 35:3771–3778. 2014. View Article : Google Scholar
|
|
47
|
Chen L, Wang J, Fu L, Zhang B, Zhang H and
Ye B: Prognostic significance of metastasis associated in colon
cancer 1 (MACC1) expression in patients with gallbladder cancer. J
Cancer Res Ther. 10:1052–1056. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li HF, Liu YQ, Shen ZJ, Gan XF, Han JJ,
Liu YY, Li HG1 and Huang ZQ: Downregulation of MACC1 inhibits
invasion, migration and proliferation, attenuates cisplatin
resistance and induces apoptosis in tongue squamous cell carcinoma.
Oncol Rep. 33:651–660. 2015.PubMed/NCBI
|
|
49
|
Zhang K, Zhang Y, Zhu H, Xue N, Liu J,
Shan C and Zhu Q: High expression of MACC1 predicts poor prognosis
in patients with osteosarcoma. Tumor Biol. 35:1343–1350. 2014.
View Article : Google Scholar
|
|
50
|
Zhang K, Tian F, Zhang Y, Zhu Q, Xue N,
Zhu H, Wang H and Guo X: MACC1 is involved in the regulation of
proliferation, colony formation, invasion ability, cell cycle
distribution, apoptosis and tumorigenicity by altering Akt
signaling pathway in human osteosarcoma. Tumor Biol. 35:2537–2548.
2014. View Article : Google Scholar
|
|
51
|
Zhu M, Xu Y, Mao X, Gao Y, Shao L and Yan
F: Overexpression of metastasis-associated in colon cancer-1
associated with poor prognosis in patients with esophageal cancer.
Pathol Oncol Res. 19:749–753. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang JJ, Hong Q, Hu CG, Fang YJ and Wang
Y: Significance of MACC1 protein expression in esophageal
carcinoma. Zhonghua yi xue za zhi. 93:2584–2586. 2013.(In Chinese).
PubMed/NCBI
|
|
53
|
Meng FJ, Li H, Shi H, Yang Q, Zhang F,
Yang Y, Kang L, Zhen T, Dong DY and Han A: MACC1 down-regulation
inhibits proliferation and tumourigenicity of nasopharyngeal
carcinoma cells through Akt/β-catenin signaling pathway. PLoS One.
8:e608212013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wang G, Kang MX, Lu WJ, Chen Y, Zhang B
and Wu YL: MACC1: A potential molecule associated with pancreatic
cancer metastasis and chemoresistance. Oncol Lett. 4:783–791.
2012.PubMed/NCBI
|
|
55
|
Lederer A, Herrmann P, Seehofer D, Dietel
M, Pratschke J, Schlag P and Stein U: Metastasis-associated in
colon cancer 1 is an independent prognostic biomarker for survival
in klatskin tumor patients. Hepatology. 62:841–850. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Li H, Liao X, Liu Y, Shen Z, Gan X, Li H
and Huang Z: The expression of MACC1 and its role in the
proliferation and apoptosis of salivary adenoid cystic carcinoma. J
Oral Pathol Med. 44:810–817. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Guo L, Lu W, Zhang X, Luo D and Zhang H:
Metastasis-associated colon cancer-1 is a novel prognostic marker
for cervical cancer. Int J Clin Exp Pathol. 7:4150–4155.
2014.PubMed/NCBI
|
|
58
|
Shirahata A, Shinmura K, Kitamura Y,
Sakuraba K, Yokomizo K, Goto T, Mizukami H, Saito M, Ishibashi K,
Kigawa G, et al: MACC1 as a marker for advanced colorectal
carcinoma. Anticancer Res. 30:2689–2692. 2010.PubMed/NCBI
|
|
59
|
Lang AH, Geller-Rhomberg S, Winder T,
Stark N, Gasser K, Hartmann B, Kohler B, Grizelj I, Drexel H and
Muendlein A: A common variant of the MACC1 gene is significantly
associated with overall survival in colorectal cancer patients. BMC
Cancer. 12:202012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Schmid F, Burock S, Klockmeier K, Schlag
PM and Stein U: SNPs in the coding region of the
metastasis-inducing gene MACC1 and clinical outcome in colorectal
cancer. Mol Cancer. 11:492012. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Stein U, Burock S, Herrmann P, Wendler I,
Niederstrasser M, Wernecke KD and Schlag PM: Circulating MACC1
transcripts in colorectal cancer patient plasma predict metastasis
and prognosis. PLos One. 7:e492492012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Isella C, Mellano A, Galimi F, Petti C,
Capussotti L, De Simone M, Bertotti A, Medico E and Muratore A:
MACC1 mRNA levels predict cancer recurrence after resection of
colorectal cancer liver metastases. Ann Surg. 257:1089–1095. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Ren B, Zakharov V, Yang Q, McMahon L, Yu J
and Cao W: MACC1 is related to colorectal cancer initiation and
early-stage invasive growth. Am J Clin Pathol. 140:701–707. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Harpaz N, Taboada S, Ko HM, Yu J, Yang Q,
Xu H and Cao W: Expression of MACC1 and MET in inflammatory bowel
disease-associated colonic neoplasia. Inflamm Bowel Dis.
20:703–711. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yamamoto H, Miyoshi N, Mimori K, Hitora T,
Tokuoka M, Fujino S, Ellis HL, Ishii H, Noura S, Ohue M, et al:
MACC1 expression levels as a novel prognostic marker for colorectal
cancer. Oncol Lett. 8:2305–2309. 2014.PubMed/NCBI
|
|
66
|
Ilm K, Kemmner W, Osterland M, Burock S,
Koch G, Herrmann P, Schlag PM and Stein U: High MACC1 expression in
combination with mutated KRAS G13 indicates poor survival of
colorectal cancer patients. Mol Cancer. 14:382015. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Koelzer VH, Herrmann P, Zlobec I,
Karamitopoulou E, Lugli A and Stein U: Heterogeneity analysis of
metastasis associated in colon cancer 1 (MACC1) for survival
prognosis of colorectal cancer patients: A retrospective cohort
study. BMC Cancer. 15:1602015. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zhen T, Dai S, Li H, Yang Y, Kang L, Shi
H, Zhang F, Yang D, Cai S, He Y, et al: MACC1 promotes
carcinogenesis of colorectal cancer via β-catenin signaling
pathway. Oncotarget. 5:3756–3769. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Kawamura M, Saigusa S, Toiyama Y, Tanaka
K, Okugawa Y, Hiro J, Uchida K, Mohri Y, Inoue Y and Kusunoki M:
Correlation of MACC1 and MET expression in rectal cancer after
neoadjuvant chemoradiotherapy. Anticancer Res. 32:1527–1531.
2012.PubMed/NCBI
|
|
70
|
Ge Y, Meng X, Zhou Y, Zhang J and Ding Y:
Positive MACC1 expression correlates with invasive behaviors and
postoperative liver metastasis in colon cancer. Int J Clin Exp Med.
8:1094–1100. 2015.PubMed/NCBI
|
|
71
|
Galimi F, Torti D, Sassi F, Isella C, Corà
D, Gastaldi S, Ribero D, Muratore A, Massucco P, Siatis D, et al:
Genetic and expression analysis of MET, MACC1, and HGF in
metastatic colorectal cancer: Response to met inhibition in patient
xenografts and pathologic correlations. Clin Cancer Res.
17:3146–3156. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Boardman LA: Overexpression of MACC1 leads
to downstream activation of HGF/MET and potentiates metastasis and
recurrence of colorectal cancer. Genome Med. 1:362009. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Nitsche U, Rosenberg R, Balmert A,
Schuster T, Slotta-Huspenina J, Herrmann P, Bader FG, Friess H,
Schlag PM, Stein U and Janssen KP: Integrative marker analysis
allows risk assessment for metastasis in stage II colon cancer. Ann
Surg. 256:763–771. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Stroun M, Anker P, Maurice P, Lyautey J,
Lederrey C and Beljanski M: Neoplastic characteristics of the DNA
found in the plasma of cancer patients. Oncology. 46:318–322. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Kopreski MS, Benko FA, Kwak LW and Gocke
CD: Detection of tumor messenger RNA in the serum of patients with
malignant melanoma. Clin Cancer Res. 5:1961–1965. 1999.PubMed/NCBI
|
|
76
|
Silva JM, Dominguez G, Silva J, Garcia JM,
Sanchez A, Rodriguez O, Provencio M, España P and Bonilla F:
Detection of epithelial messenger RNA in the plasma of breast
cancer patients is associated with poor prognosis tumor
characteristics. Clin Cancer Res. 7:2821–2825. 2001.PubMed/NCBI
|
|
77
|
Silva JM, Rodriguez R, Garcia JM, Muñoz C,
Silva J, Dominguez G, Provencio M, España P and Bonilla F:
Detection of epithelial tumour RNA in the plasma of colon cancer
patients is associated with advanced stages and circulating tumour
cells. Gut. 50:530–534. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Garcia V, Garcia JM, Silva J, Martin P,
Peña C, Dominguez G, Diaz R, Herrera M, Maximiano C, Sabin P, et
al: Extracellular tumor-related mRNA in plasma of lymphoma patients
and survival implications. PLoS One. 4:e81732009. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Stein U, Burock S, Herrmann P, Wendler I,
Niederstrasser M, Wernecke KD and Schlag PM: Diagnostic and
prognostic value of metastasis inducer S100A4 transcripts in plasma
of colon, rectal, and gastric cancer patients. J Mol Diagn.
13:189–198. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Mohammed N, Rodriguez M, Garcia V, Garcia
JM, Dominguez G, Peña C, Herrera M, Gomez I, Diaz R, Soldevilla B,
et al: EPAS1 mRNA in plasma from colorectal cancer patients is
associated with poor outcome in advanced stages. Oncol Lett.
2:719–724. 2011.PubMed/NCBI
|
|
81
|
Shen J, Wei J, Guan W, Wang H, Ding Y,
Qian X, Yu L, Zou Z, Xie L, Costa C, et al: Plasma mRNA expression
levels of BRCA1 and TS as potential predictive biomarkers for
chemotherapy in gastric cancer. J Transl Med. 12:3552014.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Kishikawa T, Otsuka M, Ohno M, Yoshikawa
T, Takata A and Koike K: Circulating RNAs as new biomarkers for
detecting pancreatic cancer. World J Gastroenterol. 21:8527–8540.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
García JM, García V, Peña C, Domínguez G,
Silva J, Diaz R, Espinosa P, Citores MJ, Collado M and Bonilla F:
Extracellular plasma RNA from colon cancer patients is confined in
a vesicle-like structure and is mRNA-enriched. RNA. 14:1424–1432.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Zheng Z, Gao S, Yang Z, Xie H, Zhang C,
Lin B, Wu L, Zheng S and Zhou L: Single nucleotide polymorphisms in
the metastasis-associated in colon cancer-1 gene predict the
recurrence of hepatocellular carcinoma after transplantation. Int J
Med Sci. 11:142–150. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Siravegna G, Mussolin B, Buscarino M,
Corti G, Cassingena A, Crisafulli G, Ponzetti A, Cremolini C, Amatu
A, Lauricella C, et al: Clonal evolution and resistance to EGFR
blockade in the blood of colorectal cancer patients. Nat Med.
21:795–801. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Mouliere F, Robert B, Arnau Peyrotte E,
Del Rio M, Ychou M, Molina F, Gongora C and Thierry AR: High
fragmentation characterizes tumour-derived circulating DNA. PLoS
One. 6:e234182011. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Bettegowda C, Sausen M, Leary RJ, Kinde I,
Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, et al:
Detection of circulating tumor DNA in early- and late-stage human
malignancies. Sci Transl Med. 6:224ra2242014. View Article : Google Scholar
|
|
88
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
96:(Suppl). R40–R44. 2007.PubMed/NCBI
|
|
89
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Zhang Y, Wang ZQ, Chen M, Peng L, Wang X,
Ma Q, Ma F and Jiang B: MicroRNA-143 targets MACC1 to inhibit cell
invasion and migration in colorectal cancer. Mol Cancer. 11:232012.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Huang N, Wu Z, Lin L, Zhou M, Wang L, Ma
H, Xia J, Bin J, Liao Y and Liao W: MiR-338-3p inhibits
epithelial-mesenchymal transition in gastric cancer cells by
targeting ZEB2 and MACC1/Met/Akt signaling. Oncotarget.
6:15222–15234. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Feng J, Wang J, Chen M, Chen G, Wu Z, Ying
L, Zhuo Q, Zhang J and Wang W: miR-200a suppresses cell growth and
migration by targeting MACC1 and predicts prognosis in
hepatocellular carcinoma. Oncol Rep. 33:713–720. 2015.PubMed/NCBI
|
|
93
|
Xue Q, Sun K, Deng HJ, Lei ST, Dong JQ and
Li GX: MicroRNA-338-3p inhibits colorectal carcinoma cell invasion
and migration by targeting smoothened. Jpn J Clin Oncol. 44:13–21.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Sun K, Su G, Deng H, Dong J, Lei S and Li
G: Relationship between miRNA-338-3p expression and progression and
prognosis of human colorectal carcinoma. Chin Med J (Engl).
127:1884–1890. 2014.PubMed/NCBI
|
|
95
|
Sheng XJ, Li Z, Sun M, Wang ZH, Zhou DM,
Li JQ, Zhao Q, Sun XF and Liu QC: MACC1 induces metastasis in
ovarian carcinoma by upregulating hepatocyte growth factor receptor
c-MET. Oncol Lett. 8:891–897. 2014.PubMed/NCBI
|
|
96
|
Pichler M, Ress AL, Winter E, Stiegelbauer
V, Karbiener M, Schwarzenbacher D, Scheideler M, Ivan C, Jahn SW,
Kiesslich T, et al: MiR-200a regulates epithelial to mesenchymal
transition-related gene expression and determines prognosis in
colorectal cancer patients. Br J Cancer. 110:1614–1621. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Lin L, Huang H and Liao W, Ma H, Liu J,
Wang L, Huang N, Liao Y and Liao W: MACC1 supports human gastric
cancer growth under metabolic stress by enhancing the Warburg
effect. Oncogene. 34:2700–2710. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Hara S, Nakashiro K, Klosek SK, Ishikawa
T, Shintani S and Hamakawa H: Hypoxia enhances c-Met/HGF receptor
expression and signaling by activating HIF-1alpha in human salivary
gland cancer cells. Oral Oncol. 42:593–598. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Chen HH, Su WC, Lin PW, Guo HR and Lee WY:
Hypoxia-inducible factor-1alpha correlates with MET and metastasis
in node-negative breast cancer. Breast Cancer Res Treat.
103:167–175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Comito G, Calvani M, Giannoni E, Bianchini
F, Calorini L, Torre E, Migliore C, Giordano S and Chiarugi P:
HIF-1α stabilization by mitochondrial ROS promotes Met-dependent
invasive growth and vasculogenic mimicry in melanoma cells. Free
Radic Biol Med. 51:893–904. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Ide T, Kitajima Y, Miyoshi A, Ohtsuka T,
Mitsuno M, Ohtaka K and Miyazaki K: The hypoxic environment in
tumor-stromal cells accelerates pancreatic cancer progression via
the activation of paracrine hepatocyte growth factor/c-Met
signaling. Ann Surg Oncol. 14:2600–2607. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Kim BW, Cho H, Chung JY, Conway C, Ylaya
K, Kim JH and Hewitt SM: Prognostic assessment of hypoxia and
metabolic markers in cervical cancer using automated digital image
analysis of immunohistochemistry. J Transl Med. 11:1852013.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Chen Z, He X, Xia W, Huang Q, Zhang Z, Ye
J, Ni C, Wu P, Wu D, Xu J, et al: Prognostic value and
clinicopathological differences of HIFs in colorectal cancer:
Evidence from meta-analysis. PLoS One. 8:e803372013. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Hardie DG: The AMP-activated protein
kinase pathway-new players upstream and downstream. J Cell Sci.
117:5479–5487. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Loo JM, Scherl A, Nguyen A, Man FY,
Weinberg E, Zeng Z, Saltz L, Paty PB and Tavazoie SF: Extracellular
metabolic energetics can promote cancer progression. Cell.
160:393–406. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Fűri I, Kalmár A, Wichmann B, Spisák S,
Schöller A, Barták B, Tulassay Z and Molnár B: Cell free DNA of
tumor origin induces a ‘metastatic’ expression profile in HT-29
cancer cell line. PLoS One. 10:e01316992015. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Fűri I, Sipos F, Germann TM, Kalmár A,
Tulassay Z, Molnár B and Műzes G: Epithelial toll-like receptor 9
signaling in colorectal inflammation and cancer: Clinico-pathogenic
aspects. World J Gastroenterol. 19:4119–4126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Juneja M, Ilm K, Schlag PM and Stein U:
Promoter identification and transcriptional regulation of the
metastasis gene MACC1 in colorectal cancer. Mol Oncol. 7:929–943.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Stein U, Smith J, Walther W and Arlt F:
MACC1 controls Met: What a difference an Sp1 site makes. Cell
Cycle. 8:2467–2469. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Wang L, Lin L, Chen X, Sun L, Liao Y,
Huang N and Liao W: Metastasis-associated in colon cancer-1
promotes vasculogenic mimicry in gastric cancer by upregulating
TWIST1/2. Oncotarget. 6:11492–11506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Migliore C, Martin V, Leoni VP, Restivo A,
Atzori L, Petrelli A, Isella C, Zorcolo L, Sarotto I, Casula G, et
al: MiR-1 downregulation cooperates with MACC1 in promoting MET
overexpression in human colon cancer. Clin Cancer Res. 18:737–747.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Shang C, Hong Y, Guo Y, Liu YH and Xue YX:
Influence of the MACC1 gene on sensitivity to chemotherapy in human
U251 glioblastoma cells. Asian Pac J Cancer Prev. 16:195–199. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Yang WJ, Song MJ, Park EY, Lee JJ, Park
JH, Park K, Park JH and Kim HP: Transcription factors Sp1 and Sp3
regulate expression of human ABCG2 gene and chemoresistance
phenotype. Mol Cells. 36:368–375. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Gao Y, Liu Z, Zhang X, He J, Pan Y, Hao F,
Xie L, Li Q, Qiu X and Wang E: Inhibition of cytoplasmic GSK-3β
increases cisplatin resistance through activation of Wnt/β-catenin
signaling in A549/DDP cells. Cancer Lett. 336:231–239. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Wei Y, Shen N, Wang Z, Yang G, Yi B, Yang
N, Qiu Y and Lu J: Sorafenib sensitizes hepatocellular carcinoma
cell to cisplatin via suppression of Wnt/β-catenin signaling. Mol
Cell Biochem. 381:139–144. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Zhao H, Wei W, Sun Y, Gao J, Wang Q and
Zheng J: Interference with the expression of β-catenin reverses
cisplatin resistance in A2780/DDP cells and inhibits the
progression of ovarian cancer in mouse model. DNA Cell Biol.
34:55–62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Xia Y, He Z, Liu B, Wang P and Chen Y:
Downregulation of Meg3 enhances cisplatin resistance of lung cancer
cells through activation of the WNT/β-catenin signaling pathway.
Mol Med Rep. 12:4530–4537. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Nagaraj AB, Joseph P, Kovalenko O, Singh
S, Armstrong A, Redline R, Resnick K, Zanotti K, Waggoner S and
DiFeo A: Critical role of Wnt/β-catenin signaling in driving
epithelial ovarian cancer platinum resistance. Oncotarget.
6:23720–23734. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Kim YH, Kim G, Kwon CI, Kim JW, Park PW
and Hahm KB: TWIST1 and SNAI1 as markers of poor prognosis in human
colorectal cancer are associated with the expression of ALDH1 and
TGF-β1. Oncol Rep. 31:1380–1388. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Yu H, Jin GZ, Liu K, Dong H, Yu H, Duan
JC, Li Z, Dong W, Cong WM and Yang JH: Twist2 is a valuable
prognostic biomarker for colorectal cancer. World J Gastroenterol.
19:2404–2411. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Di Renzo MF, Olivero M, Giacomini A, Porte
H, Chastre E, Mirossay L, Nordlinger B, Bretti S, Bottardi S,
Giordano S, et al: Overexpression and amplification of the met/HGF
receptor gene during the progression of colorectal cancer. Clin
Cancer Res. 1:147–154. 1995.PubMed/NCBI
|
|
122
|
Mao W, Irby R, Coppola D, Fu L, Wloch M,
Turner J, Yu H, Garcia R, Jove R and Yeatman TJ: Activation of
c-Src by receptor tyrosine kinases in human colon cancer cells with
high metastatic potential. Oncogene. 15:3083–3090. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Zeng Z, Weiser MR, D'Alessio M, Grace A,
Shia J and Paty PB: Immunoblot analysis of c-Met expression in
human colorectal cancer: Overexpression is associated with advanced
stage cancer. Clin Exp Metastasis. 21:409–417. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Zeng ZS, Weiser MR, Kuntz E, Chen CT, Khan
SA, Forslund A, Nash GM, Gimbel M, Yamaguchi Y, Culliford AT IV, et
al: c-Met gene amplification is associated with advanced stage
colorectal cancer and liver metastases. Cancer Lett. 265:258–269.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Osada S, Matsui S, Komori S, Yamada J,
Sanada Y, Ihawa A, Tanaka Y, Tokuyama Y, Okumura N, Nonaka K, et
al: Effect of hepatocyte growth factor on progression of liver
metastasis in colorectal cancer. Hepatogastroenterology. 57:76–80.
2010.PubMed/NCBI
|
|
126
|
Matsui S, Osada S, Tomita H, Komori S,
Mori R, Sanada Y, Takahashi T, Yamaguchi K and Yoshida K: Clinical
significance of aggressive hepatectomy for colorectal liver
metastasis, evaluated from the HGF/c-Met pathway. Int J Oncol.
37:289–297. 2010.PubMed/NCBI
|
|
127
|
Sun YL, Liu WD, Ma GY, Gao DW, Jiang YZ,
Liu Q and Du JJ: Expression of HGF and Met in human tissues of
colorectal cancers: Biological and clinical implications for
synchronous liver metastasis. Int J Med Sci. 10:548–559. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Abou-Bakr AA and Elbasmi A: c-MET
overexpression as a prognostic biomarker in colorectal
adenocarcinoma. Gulf J Oncolog. 1:28–34. 2013.PubMed/NCBI
|
|
129
|
Sueta A, Yamamoto Y, Yamamoto-Ibusuki M,
Hayashi M, Takeshita T, Yamamoto S, Omoto Y and Iwase H:
Differential role of MACC1 expression and its regulation of the
HGF/cMet pathway between breast and colorectal cancer. Int J Oncol.
46:2143–2153. 2015.PubMed/NCBI
|
|
130
|
Pichorner A, Sack U, Kobelt D, Smith J,
Walther W, Schlag PM and Stein U: In vivo imaging of MACC1 induced
metastasis formation in a xenograft mouse model based on an
IRES-vector harboring the reporter luciferase and the gene MACC1:
PO125. Onkologie. 33:652010.PubMed/NCBI
|
